InterventionsReview

Contemporary non-statin therapies for dyslipidemia management: achieving current lipid targets

Figure 1. Mechanisms of action of non-statin therapies across cholesterol metabolism. — Figure 1. Mechanisms of action of non-statin therapies across cholesterol metabolism.Mechanisms of action of non-statin therapies across cholesterol metabolism.Ponte-Negretti et al.

Frontiers in Medicine

The paper

Carlos Ignacio Ponte-Negretti, Alberto J. Lorenzatti, F Quintana,

Rodrigo Alonso K, Máxima Méndez-Castillo, Osiris Valdez-Tiburcio, Vladimir E. Ullauri-Solórzano, Camila Y. Ullauri-Valcárcel, Adriana Puente-Barragán, Luz Clemencia Zárate-Correa, José Guillermo Prieto-Marín, Isaac Alexander Suárez Sangucho, Jorge Vasconez-Gonzalez,

Esteban Ortiz‐Prado

Instituto Médico La Floresta · Universidad de las Américas

Frontiers in Medicine · 24 Aug 2026

doi.org/10.3389/fmed.2026.1894845 PubMed 42708006

Risk factors for atherosclerosis diverge across vascular beds
American Journal of Preventive Cardiology · 4 Oct 2026
Martin-Hopkins LDL equation best predicts cardiovascular risk
Circulation Population Health and Outcomes · 4 Oct 2026
Estimated sdLDL-C predicts cardiovascular risk in Japanese adults
Journal of Clinical Lipidology · 4 Oct 2026
Lipid accumulation index linked to cardiometabolic multimorbidity
The Journal of the Egyptian Public Health Association · 5 Oct 2026